Circulating Tumor Cells Predict Response to the DLL3-targeting Bispecific Antibody Tarlatamab.
循环肿瘤细胞可预测对靶向 DLL3 的双特异性抗体 Tarlatamab 的反应。
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-25-1483
Mishra Avanish, Meador Catherine B, Kikkeri Kruthika, Cunneely Quinn, Lin Maoxuan, Carmona-LaSalle Thomas J, Huang Shih-Bo, Bell Remy, Putaturo Victor, Xia Weikun, Liang Joyce H, Fang Jacy, San Vicente Sarah, Zielinski Caroline E, Digumarthy Subba R, Hung Yin P, Yeap Beow Y, Edd Jon F, Lawrence Michael S, Sade-Feldman Moshe, Sen Debattama R, Toner Mehmet, Maheswaran Shyamala, Gainor Justin F, Haber Daniel A